An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite^®

David Granet1 University of California at San Diego, San Diego, CA, USA

Steven J Lichtenstein2 University of Illinois College of Medicine at Peoria and Chicago, Chicago, IL, USA

Bruce Onofrey3 UC Berkeley College of Optometry, Albuquerque, NM, USACorrespondence[email protected]

James A Katz4 The Midwest Center for Sight, Des Plaines, IL, USA

Pages 519-525 | Published online: 25 Nov 2022

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

AlexandrakisGAlfonsoEMillerD2000Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolonesOphthalmol1071497502
PubMed Web of Science ®Google Scholar
The American Academy of Ophthalmology2003Preferred practice pattern for conjunctivitis [online]. Accessed 10 October, 2007. URL: http://www.aao.org/education/guidelines/ppp/conjunctivitis_new.cfm
Google Scholar
Azasite [package insert]2007 Inspire Pharmaceuticals, Durham, NC.
Google Scholar
BradshawJ2006Ophthalmology: spreading the word on compliancePaediatr Nurs182117193914
PubMedGoogle Scholar
BartlettJDJaanusSD2005Clinical ocular pharmacologyBoston, MAButterworth-Heinemann411
Google Scholar
BryskierA2005FluoroquinolonesBryskierAAntimicrobial agents: antibacterials and antifungalsWashington, DCASM Press668788
Google Scholar
BryskierABergogne-BérézinE2005MacrolidesBryskierAAntimicrobial agents: antibacterials and antifungalsWashington, DCASM Press475526
Google Scholar
BuznachNDaganRGreenbergD2005Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance eraPediatr Infect Dis J24823816148850
PubMed Web of Science ®Google Scholar
CarbonC1998Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogensClin Infect Dis2728329675445
PubMed Web of Science ®Google Scholar
ChaudhryNAFlynnHWMurrayTG1999Emerging ciprofloxacin-resistant Pseudomonas aeruginosaAm J Ophthalmol1285091010577596
PubMed Web of Science ®Google Scholar
CraigJPTomlinsonA1995Effect of age on tear osmolalityOptom Vis Sci7271378570160
PubMed Web of Science ®Google Scholar
DonnenfeldEPerryHDChruscickiDA2004A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerabilityCurr Med Res Opin201753815537475
PubMed Web of Science ®Google Scholar
FarrisRLStuchellRNMandelID1981Basal and reflex human tear analysis. I. Physical measurements: osmolarity, basal volumes, and reflex flow rateOphthalmology8885277322504
PubMed Web of Science ®Google Scholar
FurrerPMayerJMGurnyR2002Ocular tolerance of preservatives and alternativesEur J Pharm Biopharm532638011976014
PubMed Web of Science ®Google Scholar
GurwitzJHGlynnRJMonaneM1993Treatment for glaucoma: adherence by the elderlyAm J Public Health8371168484454
PubMed Web of Science ®Google Scholar
GigliottiFHendleyJOMorganJ1984Efficacy of topical antibiotic therapy in acute conjunctivitis in childrenJ Pediatr10462366323667
PubMed Web of Science ®Google Scholar
GoldsteinMHKowalskiRPGordonYJ1999Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year reviewOphthalmology1061313810406613
PubMed Web of Science ®Google Scholar
JampelHDSchwartzGFRobinAL2003Patient preferences for eye drop characteristics: a willingness-to-pay analysisArch Ophthalmol121540612695251
PubMed Web of Science ®Google Scholar
KassMAMeltzerDWGordonM1986Compliance with topical pilocarpine treatmentAm J Ophthalmol101515233706455
PubMed Web of Science ®Google Scholar
KassMAGordonMMorleyRE1987Compliance with topical timolol treatmentAm J Ophthalmol103188933812621
PubMed Web of Science ®Google Scholar
KonstasAGMaskalerisGGratsonidisS2000Compliance and viewpoint of glaucoma patients in GreeceEye14752611116698
PubMed Web of Science ®Google Scholar
LeibowitzHMHyndiukRASmolinGR1981Tobramycin in external eye disease: a double-masked study vs. gentamicinCurr Eye Res1259667030632
PubMed Web of Science ®Google Scholar
MaguenEMorganMA2007A case of vancomycin-resistant enterococcus conjunctivitis and its clinically successful topical treatmentCornea26223417251818
PubMed Web of Science ®Google Scholar
LaMotteJORidderWHKuanT2002The effect of artificial tears with different CMC formulations on contrast sensitivityInvest Ophthalmol Vis Sci ARVO poster 3151.
Google Scholar
NoeckerRJ2006Comparison of initial treatment response to two enhanced-viscosity artificial tearsEye Contact Lens321485216702870
PubMedGoogle Scholar
PatelSCSpaethGL1995Compliance in patients prescribed eyedrops for glaucomaOphthalmic Surg2623367651690
PubMedGoogle Scholar
PatelPBDiazMCBennettJE2007Clinical features of bacterial conjunctivitis in childrenAcad Emerg Med141517119185
PubMed Web of Science ®Google Scholar
ShayaFT2005Compliance with medicineOphthalmol Clin North Am18611716314223
PubMedGoogle Scholar
Vigamox [package insert]2003Fort Worth, TXAlcon Laboratories, Inc
Google Scholar
WinfieldAJJessimanDWilliamsA1990A study of the causes of non-compliance by patients prescribed eyedropsBr J Ophthalmol74477802390523
PubMed Web of Science ®Google Scholar
WispelwayB2005Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolonesClin Infect Dis41S1273515942879
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite^®

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite®

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite^®